PURIFICATION AND PARTIAL CHARACTERIZATION OF EQUINE INFECTIOUS-ANEMIA VIRUS REVERSE-TRANSCRIPTASE

被引:20
作者
DEVICO, A
MONTELARO, RC
GALLO, RC
SARNGADHARAN, MG
机构
[1] ADV BIOSCI LABS INC,DEPT CELL BIOL,KENSINGTON,MD 20895
[2] UNIV PITTSBURGH,DEPT MOLEC GENET,PITTSBURGH,PA 15260
[3] UNIV PITTSBURGH,DEPT BIOCHEM,PITTSBURGH,PA 15260
[4] NCI,TUMOR CELL BIOL LAB,BALTIMORE,MD 21211
关键词
D O I
10.1016/0042-6822(91)90786-B
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously we raised a rabbit monospecific antibody (C2003) against a synthetic peptide derived from a sequence within the C-terminal portion of the reverse transcriptase (RT) of the human immunodeficiency virus type 1 (HIV-1). This sequence is found to be conserved in the predicted amino acid sequence of a related lentivirus, the equine infectious anemia virus (EIAV). It was previously determined that the C2003 antibody could cross-react with native EIAV RT and directly inhibit the DNA polymerase activity of the enzyme. We have now fractionated EIAV RT by immunoaffinity chromatography with immobilized C2003 antibody. The procedure yielded an equimolar mixture of two proteins of 66 and 51 kDa associated with both DNA polymerase and RNase H activities. When the EIAV RT proteins were examined by in situ activity gel assays, polymerase activity was found to be principally associated with the 66-kDa component. The fidelity of DNA synthesis by EIAV RT was found to be equivalent to that of HIV-1 RT and lower than that of AMV RT. These observations indicate that the RTs of EIAV and HIV-1 share similar structural and functional properties. © 1991.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 38 条
[1]   HIV-1 REVERSE-TRANSCRIPTASE - STRUCTURE PREDICTIONS FOR THE POLYMERASE DOMAIN [J].
BARBER, AM ;
HIZI, A ;
MAIZEL, JV ;
HUGHES, SH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1061-1072
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]  
BATTULA N, 1974, J BIOL CHEM, V249, P4086
[4]  
BATTULA N, 1976, J BIOL CHEM, V251, P982
[5]  
BEBENEK K, 1989, J BIOL CHEM, V264, P16948
[6]   HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III - IMMUNOLOGICAL CHARACTERIZATION AND PRIMARY STRUCTURE-ANALYSIS OF THE MAJOR INTERNAL PROTEIN, P24 [J].
CASEY, JM ;
KIM, Y ;
ANDERSEN, PR ;
WATSON, KF ;
FOX, JL ;
DEVARE, SG .
JOURNAL OF VIROLOGY, 1985, 55 (02) :417-423
[7]   GENOMIC CHANGES ASSOCIATED WITH ANTIGENIC VARIATION OF VISNA VIRUS DURING PERSISTENT INFECTION [J].
CLEMENTS, JE ;
PEDERSEN, FS ;
NARAYAN, O ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (08) :4454-4458
[8]   HIGH PREVALENCE OF SERUM ANTIBODIES TO REVERSE-TRANSCRIPTASE IN HIV-1-INFECTED INDIVIDUALS [J].
DEVICO, AL ;
VERONESE, FD ;
LEE, SL ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (01) :17-22
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 REVERSE-TRANSCRIPTASE [J].
DEVICO, AL ;
COPELAND, TD ;
VERONESE, FD ;
OROSZLAN, S ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (01) :51-60
[10]  
DEVICO AL, 1991, J BIOL CHEM, V266, P6774